{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:55:52Z","timestamp":1791356152942,"version":"4.3.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.autrev.2012.10.002","type":"journal-article","created":{"date-parts":[[2012,11,24]],"date-time":"2012-11-24T01:00:34Z","timestamp":1353718834000},"page":"599-606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Immunomodulation in psoriatic arthritis: Focus on cellular and molecular pathways"],"prefix":"10.1016","volume":"12","author":[{"given":"Maria Sole","family":"Chimenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Ballanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2012.10.002_bb0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.berh.2006.02.002","article-title":"Psoriatic arthritis: one or more diseases?","volume":"20","author":"Fitzgerald","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0010","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","article-title":"A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience","volume":"42","author":"Kane","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2012.10.002_bb0015","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/1529-0131(199906)42:6<1080::AID-ANR2>3.0.CO;2-7","article-title":"Psoriatic arthritis: a unified concept twenty years on","volume":"42","author":"McGonagle","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2012.10.002_bb0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.autrev.2011.04.010","article-title":"Anti-TNF therapy: safety aspects of taking the risk","volume":"10","author":"Rosenblum","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.002_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/1874312901105010133","article-title":"Synovial tissue response to treatment in psoriatic arthritis","volume":"5","author":"Codullo","year":"2011","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.autrev.2012.10.002_bb0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0198-8859(99)00034-8","article-title":"Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis","volume":"60","author":"Tassiulas","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2009.10.005","article-title":"Expression of MDC\/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis","volume":"49","author":"Flytlie","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2012.10.002_bb0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11926-011-0181-y","article-title":"Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy","volume":"13","author":"van Kuijk","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2012.10.002_bb0045","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/art.30176","article-title":"Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.002_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2249.2009.04039.x","article-title":"Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity?","volume":"159","author":"Koenders","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/ar1478","article-title":"The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models","volume":"7","author":"Lubberts","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.10.002_bb0060","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.10.002_bb0065","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.23655","article-title":"Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides","volume":"58","author":"Jandus","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.002_bb0070","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ni1460","article-title":"Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17","volume":"8","author":"Leibundgut-Landmann","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0075","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","article-title":"Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial","volume":"373","author":"Gottlieb","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2012.10.002_bb0080","first-page":"518","article-title":"Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid","volume":"24","author":"Partsch","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0085","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00393-002-0415-5","article-title":"IgVH-genes analysis from psoriatic arthritis shows involvement of antigen-activated synovial B-lymphocytes","volume":"61","author":"Gerhard","year":"2002","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0090","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/ard.2006.062042","article-title":"Ectopic lymphoid neogenesis in psoriatic arthritis","volume":"66","author":"Ca\u00f1ete","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.10.002_bb0095","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/1529-0131(200109)44:9<2024::AID-ART351>3.0.CO;2-K","article-title":"Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis","volume":"44","author":"Fraser","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.002_bb0100","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/art.1780360705","article-title":"Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis","volume":"36","author":"Veale","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.002_bb0105","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2","article-title":"Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis","volume":"43","author":"Danning","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.002_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12016-007-0039-2","article-title":"Immunopathogenesis of psoriasis","volume":"33","author":"Nickoloff","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0115","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.berh.2006.06.010","article-title":"Spondyloarthropathy: disease at the crossroads of immunity","volume":"20","author":"FitzGerald","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2007.08.009","article-title":"Immune regulation in psoriasis and psoriatic arthritis\u2013recent developments","volume":"114","author":"Hueber","year":"2007","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2012.10.002_bb0125","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2012.10.002_bb0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0167-4889(99)00058-0","article-title":"Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type","volume":"1450","author":"Donato","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2012.10.002_bb0135","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jemt.10299","article-title":"S100A9\/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity","volume":"60","author":"Nacken","year":"2003","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.autrev.2012.10.002_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1471-4906(03)00062-0","article-title":"Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules","volume":"24","author":"Roth","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0145","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.4049\/jimmunol.171.5.2602","article-title":"Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide","volume":"171","author":"Vandal","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0150","doi-asserted-by":"crossref","first-page":"32672","DOI":"10.1074\/jbc.274.46.32672","article-title":"The two calcium-binding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils","volume":"274","author":"Kerkhoff","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.002_bb0155","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jemt.10296","article-title":"Intracellular and extracellular roles of S100 proteins","volume":"60","author":"Donato","year":"2003","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.autrev.2012.10.002_bb0160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0167-4889(98)00144-X","article-title":"Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9)","volume":"1448","author":"Kerkhoff","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2012.10.002_bb0165","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/330080a0","article-title":"Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis","volume":"330","author":"Odink","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2012.10.002_bb0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/bi001791k","article-title":"Interaction of S100A8\/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells","volume":"40","author":"Kerkhoff","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.autrev.2012.10.002_bb0175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2133.2006.07198.x","article-title":"Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis","volume":"155","author":"Benoit","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0180","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/art.10988","article-title":"Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis","volume":"48","author":"Kane","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.002_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2119\/2006-00003.Gulko","article-title":"Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis","volume":"11","author":"Batliwalla","year":"2005","journal-title":"Mol Med"},{"key":"10.1016\/j.autrev.2012.10.002_bb0190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature03963","article-title":"Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins","volume":"437","author":"Zenz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2012.10.002_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2230.1990.tb02011.x","article-title":"Complement activation in psoriasis","volume":"15","author":"Rosenberg","year":"1990","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0200","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.autrev.2011.04.012","article-title":"Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors","volume":"10","author":"Ballanti","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.002_bb0205","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.10183","article-title":"Local production of complement proteins in rheumatoid arthritis synovium","volume":"46","author":"Neumann","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.002_bb0210","first-page":"82","article-title":"Complement C3 cleavage product in synovial fluids detected by immunofixation","volume":"50","author":"Partsch","year":"1991","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0215","first-page":"225","article-title":"Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation","volume":"21","author":"Triolo","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0220","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/rheumatology\/33.7.626","article-title":"Decrease in detectable complement receptor type 1 levels on erythrocytes from patients with psoriatic polyarthritis","volume":"33","author":"Rivas","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0225","first-page":"23","article-title":"Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment","volume":"30","author":"Chimenti","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0230","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/ard.2008.094946","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Treatment recommendations for psoriatic arthritis","volume":"68","author":"Ritchlin","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2012.10.002_bb0235","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.autrev.2011.05.022","article-title":"Atherosclerosis in psoriatic arthritis","volume":"10","author":"Ramonda","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.002_bb0240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11926-008-0048-z","article-title":"Remission in psoriatic arthritis","volume":"10","author":"de Vlam","year":"2008","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.autrev.2012.10.002_bb0245","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.autrev.2011.04.015","article-title":"Anti-TNF\u03b1 discontinuation in rheumatoid and psoriatic arthritis: is it possible after disease remission?","volume":"10","author":"Chimenti","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.002_bb0250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.autrev.2007.03.003","article-title":"Biological and clinical effects of anti-TNFalpha treatment","volume":"7","author":"Valesini","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2012.10.002_bb0255","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B","article-title":"Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondyloarthropathy: histologic findings in eight patients from an open-label pilot study","volume":"44","author":"Baeten","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.002_bb0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/cyto.1999.0552","article-title":"Tumour necrosis factor alpha (TNF-a) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF therapy for RA","volume":"12","author":"Ohshima","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2012.10.002_bb0265","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2003.018549","article-title":"Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy","volume":"64","author":"Kruithof","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2012.10.002_bb0270","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/ard.2008.091389","article-title":"A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue","volume":"68","author":"van Kuijk","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.10.002_bb0275","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/ar3228","article-title":"Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy\u2014a single centre, open-label study","volume":"13","author":"Pontifex","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.10.002_bb0280","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/07853890701477546","article-title":"Rheumatoid arthritis and the complement system","volume":"39","author":"Okroj","year":"2007","journal-title":"Ann Med"},{"key":"10.1016\/j.autrev.2012.10.002_bb0285","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/jcp.2008.056317","article-title":"Complement deficiency and disease","volume":"61","author":"Unsworth","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.2007.085753","article-title":"C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice","volume":"68","author":"Blom","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.10.002_bb0295","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/immu.200310022","article-title":"Biochemical and functional characterization of the interaction between pentraxin 3 and C1q","volume":"33","author":"Nauta","year":"2003","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2012.10.002_bb0300","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.autrev.2011.04.017","article-title":"Emerging role for NK cells in the pathogenesis of inflammatory arthropathies","volume":"10","author":"Conigliaro","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.002_bb0305","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11926-004-0043-y","article-title":"Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis","volume":"6","author":"Myers","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2012.10.002_bb0310","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/art.23078","article-title":"Histopathologic changes at \u2018synovio\u2013entheseal complexes\u2019 suggesting a novel mechanism for synovitis in osteoarthritis and spondyloarthritis","volume":"56","author":"Benjamin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.002_bb0315","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaad.2010.02.049","article-title":"Markedly elevated serum levels of calcium-binding S100A8\/A9 proteins in psoriatic arthritis are due to activated monocytes\/macrophages","volume":"64","author":"Aochi","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2012.10.002_bb0320","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/14712598.8.3.363","article-title":"Adalimumab for the treatment of severe psoriasis and psoriatic arthritis","volume":"8","author":"Papoutsaki","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"10.1016\/j.autrev.2012.10.002_bb0325","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.autrev.2011.10.019","article-title":"Early treatment in early undifferentiated arthritis","volume":"11","author":"Olivieri","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.002_bb0330","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.60.4.316","article-title":"Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis","volume":"60","author":"Laloux","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.10.002_bb0335","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.autrev.2006.12.003","article-title":"Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis","volume":"6","author":"Punzi","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.002_bb0340","article-title":"Can we reduce the dosage of biologics in spondyloarthritis?","author":"Olivieri","year":"2012","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212002601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212002601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T05:50:05Z","timestamp":1540101005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212002601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1568997212002601"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.10.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulation in psoriatic arthritis: Focus on cellular and molecular pathways","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2012.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2012 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}